Stacia M. DeSantis

Stacia M. DeSantis

Auto-generated profile, based on publicly available information

Stacia M. DeSantis

Department of Biostatistics, School of Public Health, University of Texas Health Science Center at Houston, Houston, TX

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
RCRonald Chang
Ronald Chang
EFErin E. Fox
Erin E. Fox
TGThomas J. Greene
Thomas J. Greene
BEBrian J. Eastridge
Brian J. Eastridge
RGRamyar Gilani
Ramyar Gilani
JHJohn B. Holcomb
John B. Holcomb
BACKGROUND Rational development of technology for rapid control of noncompressible torso hemorrhage (NCTH) requires detailed understanding of what is bleeding. Our objectives were to describe the anatomic location of truncal bleeding in patients presenting with NCTH and compare endovascular (ENDO) management versus open (OPEN) management. METHODS This is a retrospective study of adult trauma patients with NCTH admitted to four urban Level I trauma centers in the Houston and San Antonio metropolitan areas in 2008 to 2012. Inclusion criteria include named axial torso vessel disruption, Abbreviated Injury Scale chest or abdomen score of 3 or higher with shock (base excess, <−4) or truncal operation in 90 minutes or less, or pelvic fracture with ring disruption. Exclusion criteria include isolated hip fractures, falls from standing, or prehospital cardiopulmonary resuscitation. After dichotomizing into OPEN, ENDO, and resuscitative thoracotomy (RT) groups based on the initial approach to control NCTH, a mixed-effects Poisson regression with robust error variance (controlling for age, mechanism, Injury Severity Score, shock, hypotension, and severe head injury as fixed effects and site as a random effect) was used to test the hypothesis that ENDO was associated with reduced in-hospital mortality in NCTH patients. RESULTS Five hundred forty-three patients with NCTH underwent ENDO (n = 166, 31%), OPEN (n = 309, 57%), or RT (n = 68, 12%). Anatomic bleeding locations were 25% chest, 41% abdomen, and 31% pelvis. ENDO was used to treat relatively few types of vascular injuries, whereas OPEN and RT injuries were more diverse. ENDO patients had more blunt trauma (95% vs. 34% vs. 32%); severe injuries (median Injury Severity Score, 34 vs. 27 vs. 21), and increased time to intervention (median, 298 vs. 92 vs. 51 minutes) compared with OPEN and RT. Mortality was 15% versus 20% versus 79%. ENDO was associated with decreased mortality compared to OPEN (relative risk, 0.58; 95% confidence interval, 0.46–0.73). CONCLUSION Although ENDO may reduce mortality in NCTH patients, significant group differences limit the generalizability of this finding. LEVEL OF EVIDENCE Therapeutic, level V.

1 June 2019 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
AJAllison R. Jones
Allison R. Jones
RPRakesh P. Patel
Rakesh P. Patel
MMMarisa B. Marques
Marisa B. Marques
JDJohn P. Donnelly
John P. Donnelly
RGRussell Griffin
Russell Griffin
CCConnie Colavecchia
Connie Colavecchia

17 October 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
SAShailesh Advani
Shailesh Advani
PAPragati Shailesh Advani
Pragati Shailesh Advani
DBDerek W. Brown
Derek W. Brown
SDStacia M. DeSantis
Stacia M. DeSantis
KKKrittiya Korphaisarn
Krittiya Korphaisarn
SKScott Kopetz
Scott Kopetz
Background: CpG Island Methylator Phenotype (CIMP) is an epigenetic phenotype in CRC characterized by hypermethylation of CpG islands in promoter regions of tumor suppressor genes, leading to their transcriptional silencing and loss of function. While the prevalence of CRC differs across geographical regions, no studies have compared prevalence of CIMP-High phenotype across regions. The purpose of this project was to compare the prevalence of CIMP across geographical regions after adjusting for variations in methodologies to measure CIMP in a meta-analysis.Methods: We searched PubMed, Medline, and Embase for articles focusing on CIMP published from 2000 to 2018. Two reviewers independently identified 111 articles to be included in final meta-analysis. We classified methods used to quantify CIMP into 4 categories: a) Classical (MINT marker) Panel group b) Weisenberg-Ogino (W-O) group c) Human Methylation Arrays group and d) Miscellaneous group. We compared the prevalence of CIMP across geographical regions after correcting for methodological variations using meta-regression techniques.Results: The pooled prevalence of CIMP-High across all studies was 22% (95% confidence interval:21–24%; I2 = 94.75%). Pooled prevalence of CIMP-H across Asia, Australia, Europe, North America and South America was 22, 21, 21, 27 and 25%, respectively. Meta-regression analysis identified no significant differences in the prevalence of CIMP-H across geographical regions after correction for methodological variations. In exploratory analysis, we observed variations in CIMP-H prevalence across countries.Conclusion: Although no differences were found for CIMP-H prevalence across countries, further studies are needed to compare the influence of demographic, lifestyle and environmental factors in relation to the prevalence of CIMP across geographical regions.

10 December 2020 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
DBDerek W. Brown
Derek W. Brown
TGThomas J. Greene
Thomas J. Greene
MSMichael D. Swartz
Michael D. Swartz
AWAnna V. Wilkinson
Anna V. Wilkinson
SDStacia M. DeSantis
Stacia M. DeSantis


18 July 2011 in The American Journal on Addictions
Verified
Journal Article
Open access
PDF file
KPKimber L. Price
Kimber L. Price
SDStacia M. DeSantis
Stacia M. DeSantis
ASAnnie N. Simpson
Annie N. Simpson
BTBryan K. Tolliver
Bryan K. Tolliver
AMAimee L. McRae-Clark
Aimee L. McRae-Clark
KBKathleen T. Brady
Kathleen T. Brady
Inconsistencies in reports on methamphetamine (METH) associated cognitive dysfunction may be attributed, at least in part, to the diversity of study sample features (eg, clinical and demographic characteristics). The current study assessed cognitive function in a METH-dependent population from rural South Carolina, and the impact of demographic and clinical characteristics on performance. Seventy-one male (28.2%) and female (71.8%) METH-dependent subjects were administered a battery of neurocognitive tests including the Test of Memory Malingering (TOMM), Shipley Institute of Living Scale, Paced Auditory Serial Addition Test (PASAT), Symbol Digit Modalities Test (SDMT), Grooved Pegboard Test, California Verbal Learning Test (CVLT), and Wisconsin Card Sorting Test (WCST). Demographic and clinical characteristics (eg, gender, frequency of METH use) were examined as predictors of performance. Subjects scored significantly lower than expected on one test of attention and one of fine motor function, but performed adequately on all other tests. There were no predictors of performance on attention; however, more frequent METH use was associated with better performance for males and worse for females on fine motor skills. The METH-dependent individuals in this population exhibit very limited cognitive impairment. The marked differences in education, Intellectual Quotient (IQ), and gender in our sample when compared to the published literature may contribute to these findings. Characterization of the impact of clinical and/or demographic features on cognitive deficits could be important in guiding the development of treatment interventions. (Am J Addict 2011;00:1--9)